Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

Let's talk about the popular West Pharmaceutical Services, Inc. (NYSE:WST). The company's shares received a lot of...

NEW YORK, NY / ACCESSWIRE / April 23, 2020 / West Pharmaceutical Services, Inc. (NYSE:WST) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on April 23, 2020 ...

Q1 2020 West Pharmaceutical Services Inc Earnings Call

Zacks.com featured highlights include: NextEra Energy, Kinsale Capital Group, Vectrus, Teekay Tankers and West Pharmaceutical Services

West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.

ResMed (RMD) global sales increase on ramped-up demand for its critical care support products.

Baxter (BAX) receives the CE marking and regulatory approval for the Evo IQ Syringe Infusion system that will help in optimizing efficiency for clinicians.

Google stock forms a bullish cup base. It joins IBD's Long-Term Leaders Watchlist along with two others.

Nevro (NVRO) received CE mark approval for the Senza Omnia SCS system, which is likely to boost its international presence.

The current market situation seems favorable for corporates to take debt since the COVID-19 pandemic has forced the Federal Reserve to drag down interest rate to a near-zero level.

Dividend growth might have been an investing staple of the past decade or so. But these past few months, dividend stocks have been pinching their pennies.Dozens of companies have announced dividend cuts or suspensions since the start of March. That includes more than 5% of the S&P; 500 Index. In fact, in April, more S&P; 500 companies reduced or killed off their dividends than announced payout raises.Investors - especially those nearing or in retirement - who are banking on regular cash income have been backed into a corner. The number of dividend stocks that are able to sustain their payouts is thinning, and those that can briskly grow those distributions over time are an even smaller group. (Remember: Income growth is vital; inflation erodes the spending power of stagnant dividends over time.)So where you can you look for dividend growth? Consider the DIVCON system from exchange-traded fund provider Reality Shares. DIVCON uses a five-tier rating, from 1 to 5, to gauge companies' dividend health. A DIVCON 5 rating indicates not just a healthy dividend, but a high likelihood of dividend growth. DIVCON 1 dividend stocks, on the other hand, are the likeliest to cut or suspend their payouts.Within each DIVCON rating is a composite score based on factors including free cash flow-to-dividends, profit growth, buybacks as a percentage of dividends and more.Here are seven safe dividend stocks with big dividend growth potential. Not only do these stocks boast the top DIVCON rating of 5, but they generate enough cash profits to pay their dividend several times over: a good indication that dividend growth will continue well into the future. SEE ALSO: 15 Super-Safe Dividend Stocks to Buy Now

S&P; Dow Jones Indices will make the following changes to the S&P; 500, the S&P; MidCap 400 and S&P; SmallCap 600 effective prior to the open of trading on Friday, May 22:

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P;® 500, which will become effective after close of trading today.

OPKO Health's (OPK) subsidiary, BioReference Laboratories collaborates with MagnaCare to offer antibody testing to Labor groups in New York metropolitan area.

Zacks.com featured highlights include: General Mills, Dollar General, West Pharmaceutical Services, Atlas Air Worldwide and CoreLogic

West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

West Pharmaceutical (WST) delivered earnings and revenue surprises of 23.17% and 5.39%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

As of late, it has definitely been a great time to be an investor West Pharmaceutical Services

With Q1 earnings due, medical supplies stock West Pharmaceutical is among the top stocks to watch. Will it get a boost — or be a bust?